Copyright
©The Author(s) 2022.
World J Gastroenterol. Nov 21, 2022; 28(43): 6078-6089
Published online Nov 21, 2022. doi: 10.3748/wjg.v28.i43.6078
Published online Nov 21, 2022. doi: 10.3748/wjg.v28.i43.6078
Table 1 Kyoto classification score
Endoscopic findings | Kyoto score | ||
0 | 1 | 2 | |
Atrophy1 | None, C1 | C2, C3 | O1-O3 |
Intestinal metaplasia | None | Antrum | Corpus and antrum |
Enlarged folds | Absence | Presence | - |
Nodularity | Absence | Presence | - |
Diffuse redness | None | Mild with RAC | Severe without RAC |
Table 2 Diagnostic performance of Kyoto classification for Helicobacter pylori infection
Ref. | Country | No. of patients | Sensitivity | Specificity | Accuracy | |
Non-infection | ||||||
RAC | Garcés-Durán et al[22], 2019 | Spain | 140 | 100 | 49.0 | 65.0 |
Yoshii et al[17], 2020 | Japan | 485 | 89.1 | 79.8 | 85.6 | |
Zhao et al[19], 2020 | China | 583 | 62.4 | 73.7 | 69.3 | |
Ebigbo et al[23], 2021 | Germany | 200 | 80.8 | 57.4 | - | |
Fiuza et al[20], 2021 | Brazil | 187 | 70.7 | 87.2 | 74.9 | |
Glover et al[24], 2021 | UK | 153 | 78.4 | 64.3 | 75.8 | |
Yuan et al[21], 2021 | China | 165 | 51.4 | 96.7 | 76.4 | |
Hirai et al[18], 2021 | Japan | 1761 | 93.2 | 83.2 | 90.6 | |
Current infection | ||||||
Atrophy | Toyoshima et al[27], 2018 | Japan | 136 | 82.6 | 85.8 | 85.3 |
Zhao et al[19], 2020 | China | 583 | 54.9 | 61.1 | 58.5 | |
Ebigbo et al[23], 2021 | Germany | 200 | 80.4 | 69.7 | - | |
Intestinal metaplasia | Toyoshima et al[27], 2018 | Japan | 136 | 39.1 | 95.6 | 86.0 |
Enlarged folds | Toyoshima et al[27], 2018 | Japan | 136 | 17.4 | 99.1 | 85.3 |
Yoshii et al[17], 2020 | Japan | 494 | 23.1 | 96.6 | 85.0 | |
Nodularity | Toyoshima et al[27], 2018 | Japan | 136 | 8.7 | 100 | 84.6 |
Yoshii et al[17], 2020 | Japan | 494 | 6.4 | 98.3 | 83.8 | |
Toyoshima et al[28], 2020 | Japan | 265 | 33.3 | 99.6 | 89.1 | |
Fiuza et al[20], 2021 | Brazil | 187 | 10.6 | 98.6 | 76.5 | |
Diffuse redness | Toyoshima et al[27], 2018 | Japan | 136 | 52.2 | 93.8 | 86.8 |
Yoshii et al[17], 2020 | Japan | 485 | 60.0 | 94.7 | 89.7 | |
Zhao et al[19], 2020 | China | 583 | 20.3 | 97.6 | 65.0 | |
Fiuza et al[20], 2021 | Brazil | 187 | 80.9 | 73.6 | 75.4 | |
Total Kyoto score | Toyoshima et al[27], 20181 | Japan | 136 | 78.3 | 92.0 | 89.7 |
Sumi et al[30], 20222 | Japan | 561 | 98.7 | 98.4 | 98.6 |
Table 3 Gastric cancer incidence based on endoscopic atrophy
Ref. | Population | No. of subjects | No. of cancers | Duration, yr | Gastric cancer incidence, %/yr | ||
Atrophy (mild) | Atrophy (moderate) | Atrophy (severe) | |||||
Shichijo et al[39], 20161,2 | Post eradication | 573 | 21 | 6.2 ± 4.8 | 0.07 | 0.34 | 1.60 |
Kaji et al[40], 20193 | Screening | 12941 | 63 | 3.7 ± 0.8 | 0.10 | 0.16 | 0.31 |
Post eradication | 2571 | 20 | 3.7 ± 0.8 | 0.06 | 0.12 | 0.42 | |
Take et al[41], 20201 | Post eradication | 2737 | 68 | 7.1 ± 5.4 | 0.15 | 0.29 | 0.67 |
Table 4 Odds ratio for histological subtype of gastric cancer based on the Kyoto classification
Ref. | H. pylori status | No. of subjects | No. of GC | No. of diffuse-type GC | No. of intestinal-type GC | OR for GC | OR for diffuse-type GC | OR for intestinal-type GC | |
Atrophy | Sekikawa et al[43], 2016 | Current, past, and no infection | 1823 | 29 | 3 | 26 | 7.41 | ||
Toyoshima et al[44], 2021 | Current infection | 499 | 132 | 39 | 93 | 2.8 | 2.3 | 6.2 | |
Kawamura et al[45], 2022 | Current, past, and no infection | 380 | 115 | 19 | 96 | 2.51 | |||
Intestinal metaplasia | Shichijo et al[48], 2017 | Current, past, and no infection | 3392 | 107 | 22 | 85 | 0.22 | ||
Toyoshima et al[44], 2021 | Current infection | 499 | 132 | 39 | 93 | 1.6 | 1.7 | ||
Enlarged folds | Nishibayashi et al[81], 2003 | Current infection | 276 | 135 | 69 | 66 | 5.0 | ||
Toyoshima et al[44], 2021 | Current infection | 499 | 132 | 39 | 93 | 0.5 | |||
Nodularity | Nishikawa et al[53], 2018 | Current infection | 674 | 25 | 9 | 16 | 10.0 | ||
Toyoshima et al[44], 2021 | Current infection | 499 | 132 | 39 | 93 | 0.5 | 0.3 | ||
RAC | Kawamura et al[45], 2022 | Current, past, and no infection | 380 | 115 | 19 | 96 | 0.23 | ||
Total Kyoto score | Toyoshima et al[44], 2021 | Current infection | 499 | 132 | 39 | 93 | 1.6 | 1.3 | 1.7 |
Lin et al[61], 2022 | Current, past, and no infection | 1848 | 37 | - | - | 1.5 |
Table 5 Odds ratio of gastric cancer after Helicobacter pylori eradication based on the Kyoto classification
- Citation: Toyoshima O, Nishizawa T. Kyoto classification of gastritis: Advances and future perspectives in endoscopic diagnosis of gastritis. World J Gastroenterol 2022; 28(43): 6078-6089
- URL: https://www.wjgnet.com/1007-9327/full/v28/i43/6078.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i43.6078